Global Insulin Glargine Market Outlook 2016-2021

Published: Dec, 2016 | Pages: 116 | Publisher: Gen Consulting Company
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Insulin glargine, marketed under the names Lantus among others, is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with diabetes. It consists of microcrystals that slowly release insulin, giving a long duration of action of 18 to 26 hours, with a "peakless" profile (according to the insulin glargine package insert). Pharmacokinetically, it resembles basal insulin secretion of non-diabetic pancreatic beta cells. Sometimes, in type 2 diabetes and in combination with a short acting sulfonylurea (drugs which stimulate the pancreas to make more insulin), it can offer moderate control of serum glucose levels. In the absence of endogenous insulin-type 1 diabetes, depleted type 2 (in some cases) or latent autoimmune diabetes of adults in late stage-insulin glargine needs the support of fast acting insulin taken with food to reduce the effect of prandially derived glucose.

This report provides detailed analysis of worldwide markets for Insulin Glargine from 2011-2015 and provides extensive market forecasts 2016-2021 by region/country and subsectors. It covers the key technological and market trends in the Insulin Glargine market and further lays out an analysis of the factors influencing the supply/demand for Insulin Glargine, and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies.

GCC's report, Global Insulin Glargine Market Outlook 2016-2021, has been prepared based on the synthesis, analysis, and interpretation of information about the global Insulin Glargine market collected from specialized sources. The report covers key technological developments in the recent times and profiles leading players in the market and analyzes their key strategies. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. The major players in the global Insulin Glargine market are Sanofi (France), Novo Nordisk (Demark), Eli Lilly (USA), Tonghua Dongbao (China), Gan & Lee (China), among others.

The report provides separate comprehensive analytics for the North America, Europe, Asia-Pacific, Middle East and Africa and Rest of World. In this sector, global competitive landscape and supply/demand pattern of Insulin Glargine industry has been provided.

 Table of Contents
Part 1. Exclusive Summary

Part 2. Methodology
2.1 Research Methodology
2.2 Geographic Scope
2.3 Years Considered

Part 3. Introduction
3.1 Definition
3.2 Supply Chain Structure
3.2.1 Raw Material Supply
3.2.2 Traders & Distributors
3.2.3 Key Customers
3.3 Manufacture
3.3.1 Manufacturing Process
3.3.2 Production Cost

Part 4. Market Landscape
4.1 Global Insulin Glargine Market Size (Volume) 2011-2016
4.1.1 Overview
4.1.2 Global Insulin Glargine Production
4.1.3 Top 10 Insulin Glargine Companies (Volume Share)
4.2 Global Insulin Glargine Market Size (Value) 2011-2016
4.2.1 Overview
4.2.2 Global Insulin Glargine Production Value
4.2.3 Top 10 Insulin Glargine Companies (Revenue Share)

Part 5. Segmentation by Products
5.1 Type 1
5.2 Type 2
5.3 Type 3

Part 6. Segmentation by End-users
6.1 Customer Segment 1
6.2 Customer Segment 2
6.3 Customer Segment 3
6.4 Customer Segment 4

Part 7. Geographical Segmentation
7.1 North America Insulin Glargine Market
7.1.1 North America Market Overview
7.1.2 North America Price & Margin
7.1.3 North America Trade Balance
7.2 EMEA Insulin Glargine Market
7.2.1 EMEA Market Overview
7.2.2 EMEA Price & Margin
7.2.3 EMEA Trade Balance
7.3 Asia Pacific Insulin Glargine Market
7.3.1 Asia Pacific Market Overview
7.3.2 Asia Pacific Price & Margin
7.3.3 Asia Pacific Trade Balance

Part 8. Market Forecast
8.1 Market Size by Volume 2016-2021
8.1.1 North America
8.1.2 EMEA
8.1.3 Asia-Pacific
8.1.4 RoW
8.2 Market Size by Value 2016-2021
8.2.1 North America
8.2.2 EMEA
8.2.3 Asia-Pacific
8.2.4 RoW
8.3 Regional Consumption Forecast
8.3.1 North America
8.3.2 EMEA
8.3.3 Asia-Pacific
8.3.4 RoW
8.4 Consumption Forecast by End-users
8.5 Consumption Forecast by Products

Part 9. Company Profiles
9.1 Company A
9.1.1 Overview
9.1.2 Products Offered
9.1.3 Business Performance
9.2 Company B
9.3 Company C
9.4 Company D

Part 10. Market Dynamics
10.1 Market Drivers
10.2 Market Constraints
10.3 Market Strategies

Part 11. Competitive Landscape
11.1 Mergers & Acquisitions
11.2 New Product Launches
11.3 Expansions
11.4 Other Developments

Part 12. Appendix
Disclaimer
Analysts Certification
List of Tables and Figures

Figure Global Production 2011-2016
Figure Global Production Value (M USD) 2011-2016
Figure Top 10 Players Revenue Share 2015
Figure Regional Production 2015
Figure Regional Production Value (M USD) 2015
Figure Global Consumption by End Market 2015
Figure Insulin Glargine Product
Figure Supply Chain Structure of Insulin Glargine
Table Raw Materials Used for Insulin Glargine Production
Table Traders & Distributors of Insulin Glargine
Table Key Customers of Insulin Glargine
Figure Insulin Glargine Manufacturing Process Flow
Figure Insulin Glargine Production Cost Structure
Figure Global Insulin Glargine Market, Growth Rate
Table Global Key Vendors Production 2011-2016
Table Global Key Vendors Production Market Share 2011-2016
Figure Global Production, Capacity Utilization 2011-2016
Figure Top 10 Companies Market Share Trends
Table Global Top 10 Vendors Production 2011
Table Global Top 10 Vendors Production 2012
Table Global Top 10 Vendors Production 2013
Table Global Top 10 Vendors Production 2014
Table Global Top 10 Vendors Production 2015
Table Global Top 10 Vendors Production 2016
Figure Global Insulin Glargine Market (M USD), Growth Rate & CAGR
Table Global Key Vendors Production Value (M USD) 2011-2016
Table Global Key Vendors Production Value Market Share 2011-2016
Figure Top 10 Player Market Share Trends
Table Global Top 10 Vendors Production Value (M USD) 2011
Table Global Top 10 Vendors Production Value (M USD) 2012
Table Global Top 10 Vendors Production Value (M USD) 2013
Table Global Top 10 Vendors Production Value (M USD) 2014
Table Global Top 10 Vendors Production Value (M USD) 2015
Table Global Top 10 Vendors Production Value (M USD) 2016
Figure Prices of Major Players 2016
Figure Gross Margin of Major Players 2016
Table Types of Insulin Glargine
Figure Global Production Market Share of Insulin Glargine by Types in 2015
Table Type 1 Insulin Glargine Production 2011-2016
Table Type 1 Insulin Glargine Price Trends 2011-2016
Table Major Manufacturers of Type 1 Insulin Glargine
Table Type 2 Insulin Glargine Production 2011-2016
Table Type 2 Insulin Glargine Price Trends 2011-2016
Table Major Manufacturers of Type 2 Insulin Glargine
Table Type 3 Insulin Glargine Production 2011-2016
Table Type 3 Insulin Glargine Price Trends 2011-2016
Table Major Manufacturers of Type 3 Insulin Glargine
Figure Global Insulin Glargine Market by Key Customer Segments 2015
Table Insulin Glargine Consumed for Customer Segment 1
Table Key Customers of Insulin Glargine
Table Insulin Glargine Consumed for Customer Segment 2
Table Key Customers of Insulin Glargine
Table Insulin Glargine Consumed for Customer Segment 3
Table Key Customers of Insulin Glargine
Figure Global Insulin Glargine Market Segmentation by Geography 2015
Figure North America Insulin Glargine Capacity & Production 2011-2016
Figure North America Insulin Glargine Revenue (M USD) 2011-2016
Figure North America Insulin Glargine Price & Margin 2011-2016
Table North America Insulin Glargine Trade Balance
Figure North America Insulin Glargine Self-sufficiency
Figure EMEA Insulin Glargine Capacity & Production 2011-2016
Figure EMEA Insulin Glargine Revenue (M USD) 2011-2016
Figure EMEA Insulin Glargine Price & Margin 2011-2016
Table EMEA Insulin Glargine Trade Balance
Figure EMEA Insulin Glargine Self-sufficiency
Figure Asia Pacific Insulin Glargine Capacity & Production 2011-2016
Figure Asia Pacific Insulin Glargine Revenue (M USD) 2011-2016
Figure Asia Pacific Insulin Glargine Price & Margin 2011-2016
Table Asia Pacific Insulin Glargine Trade Balance
Figure Asia Pacific Insulin Glargine Self-sufficiency
Figure Global Production Volume Forecast 2016-2021
Table Global Production Volume 2016-2021
Table Global Production Volume Share 2016-2021
Figure North America Insulin Glargine Production Volume Forecast
Figure Global Production Value (M USD) 2016-2021
Table Global Production Value (M USD) 2016-2021
Table Global Production Value Share 2016-2021
Figure North America Insulin Glargine Production Value (M USD) Forecast
Figure Regional Consumption 2021
Table Consumption Volume by Region 2016-2021
Table Consumption Volume Share by Region 2016-2021
Figure North America Consumption 2016-2021
Figure Consumption by Key Customer Segments 2021
Table Global Insulin Glargine Market by Customer Segments 2016-2021 (Volume)
Table Global Insulin Glargine Market by Customer Segments 2016-2021 (Share)
Figure Consumption by Types 2021
Table Global Consumption Volume by Types 2016-2021
Table Global Consumption Volume Share by Types 2016-2021
Table Financial Performance 2011-2016
Figure Market Share Trend 2011-2016